Drug class in one race
Mineralocorticoid receptor drugs for Chronic Kidney Disease
2 tracked Mineralocorticoid receptor drugs in the Chronic Kidney Disease race. The class explanation lives on the Mineralocorticoid receptor page; the full indication pipeline across every mechanism is on the Chronic Kidney Disease page.
1 approved / phase 41 Phase 3
Head-to-head evidence: Balcinrenone vs Finerenone